We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Device Products » Managing Nonconforming Product: A Devicemaker’s Guide to Compliance

Other Options

PDF Edition

$397.00

PDF Edition - 3-4 Copies (10% Off)

$357.00

PDF Edition - 5-6 Copies (15% Off)

$337.00

PDF Edition - 7-9 Copies (20% Off)

$317.00

PDF Edition - 10+ Copies (25% Off)

$297.00

Managing Nonconforming Product: A Devicemaker’s Guide to Compliance

$397.00
Device Products

Product Details

Handling nonconforming products is one of the device industry's biggest headaches.

Complying with FDA rules in the Quality Systems Regulation and international standards in ISO 13485 requires an almost Holmesian ability to dig out information and make accurate deductions.

Definitions are not clear, and requirements are scattered throughout regulations. In addition, nonconforming product management has major implications for device history records and CAPA.

This management report, based on a presentation by device systems expert Dan O'Leary, does the sleuthing and deducing for you. Pertinent regulatory passages are pulled out, interpreted and illustrated with examples from actual FDA warning letters. You'll learn:

  • Clear definitions of nonconforming product and standard dispositions;
  • The difference between correction and corrective action, as well as the types of correction applicable to nonconforming product management;
  • The device history requirements for nonconforming product rework (which you won't find in the regulations);
  • How to document and justify a decision to use a nonconforming product;
  • The importance of retesting and reevaluation after rework and the relationship to acceptance activities; and
  • How to link the investigation of nonconforming products to corrective action.

Order Your Copy Today!

PDF Edition

Available Format

PDF Edition — $397

Who Will Benefit

  • Quality Managers
  • Quality Engineers
  • Quality inspection and test managers
  • Production Managers
  • Production Supervisors
  • Manufacturing Engineers
  • Regulatory affairs and compliance professionals

Multi-user Access

Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Online Library – a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.

Our Guarantee

Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing